272 related articles for article (PubMed ID: 12653847)
1. Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis.
Meager A; Wadhwa M; Dilger P; Bird C; Thorpe R; Newsom-Davis J; Willcox N
Clin Exp Immunol; 2003 Apr; 132(1):128-36. PubMed ID: 12653847
[TBL] [Abstract][Full Text] [Related]
2. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.
Meager A; Visvalingam K; Peterson P; Möll K; Murumägi A; Krohn K; Eskelin P; Perheentupa J; Husebye E; Kadota Y; Willcox N
PLoS Med; 2006 Jul; 3(7):e289. PubMed ID: 16784312
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor.
Shiono H; Wong YL; Matthews I; Liu JL; Zhang W; Sims G; Meager A; Beeson D; Vincent A; Willcox N
Int Immunol; 2003 Aug; 15(8):903-13. PubMed ID: 12882828
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies to IL-12 in myasthenia gravis patients with thymoma; effects on the IFN-gamma responses of healthy CD4+ T cells.
Zhang W; Liu JL; Meager A; Newsom-Davis J; Willcox N
J Neuroimmunol; 2003 Jun; 139(1-2):102-8. PubMed ID: 12799027
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune associations and autoantibody screening show focused recognition in patient subgroups with generalized myasthenia gravis.
Klein R; Marx A; Ströbel P; Schalke B; Nix W; Willcox N
Hum Immunol; 2013 Sep; 74(9):1184-93. PubMed ID: 23792059
[TBL] [Abstract][Full Text] [Related]
6. Spontaneously occurring neutralizing antibodies against granulocyte-macrophage colony-stimulating factor in patients with autoimmune disease.
Meager A; Wadhwa M; Bird C; Dilger P; Thorpe R; Newsom-Davis J; Willcox N
Immunology; 1999 Jul; 97(3):526-32. PubMed ID: 10447777
[TBL] [Abstract][Full Text] [Related]
7. Elevation of IL-12 p40 and its antibody in myasthenia gravis with thymoma.
Yoshikawa H; Sato K; Edahiro S; Furukawa Y; Maruta T; Iwasa K; Watanabe H; Takaoka S; Suzuki Y; Takamori M; Yamada M
J Neuroimmunol; 2006 Jun; 175(1-2):169-75. PubMed ID: 16574246
[TBL] [Abstract][Full Text] [Related]
8. Neutralizing antibodies to granulocyte-macrophage colony-stimulating factor, interleukin-1alpha and interferon-alpha but not other cytokines in human immunoglobulin preparations.
Wadhwa M; Meager A; Dilger P; Bird C; Dolman C; Das RG; Thorpe R
Immunology; 2000 Jan; 99(1):113-23. PubMed ID: 10651949
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous neutralising antibodies to interferon--alpha and interleukin-12 in thymoma-associated autoimmune disease.
Meager A; Vincent A; Newsom-Davis J; Willcox N
Lancet; 1997 Nov; 350(9091):1596-7. PubMed ID: 9393342
[No Abstract] [Full Text] [Related]
10. Thymoma-associated myasthenia gravis: On the search for a pathogen signature.
Cufi P; Soussan P; Truffault F; Fetouchi R; Robinet M; Fadel E; Berrih-Aknin S; Le Panse R
J Autoimmun; 2014 Aug; 52():29-35. PubMed ID: 24440286
[TBL] [Abstract][Full Text] [Related]
11. Radioligand-binding assay reveals distinct autoantibody preferences for type I interferons in APS I and myasthenia gravis subgroups.
Hapnes L; Willcox N; Oftedal BE; Owe JF; Gilhus NE; Meager A; Husebye ES; Wolff AS
J Clin Immunol; 2012 Apr; 32(2):230-7. PubMed ID: 22127461
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
Link J
Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
[TBL] [Abstract][Full Text] [Related]
13. [A case of thymoma-associated myasthenia gravis with antibodies against interferon-alpha--a clinico-immunological follow up of the symptoms and its titer].
Nakamori M; Matsumura T; Saito T; Kunitomi A; Iyama A; Nozaki S; Fujimura H; Shinno S
Rinsho Shinkeigaku; 2003 Sep; 43(9):544-7. PubMed ID: 14727560
[TBL] [Abstract][Full Text] [Related]
14. Expanded TCR Vbeta subsets of CD8(+) T-cells in late-onset myasthenia gravis: novel parallels with thymoma patients.
Tackenberg B; Schlegel K; Happel M; Eienbröker C; Gellert K; Oertel WH; Meager A; Willcox N; Sommer N
J Neuroimmunol; 2009 Nov; 216(1-2):85-91. PubMed ID: 19781791
[TBL] [Abstract][Full Text] [Related]
15. Incidence of autoantibodies against type I and type II interferons in a cohort of systemic lupus erythematosus patients in Slovakia.
Slavikova M; Schmeisser H; Kontsekova E; Mateicka F; Borecky L; Kontsek P
J Interferon Cytokine Res; 2003 Mar; 23(3):143-7. PubMed ID: 12716486
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies against type I interferons as an additional diagnostic criterion for autoimmune polyendocrine syndrome type I.
Meloni A; Furcas M; Cetani F; Marcocci C; Falorni A; Perniola R; Pura M; Bøe Wolff AS; Husebye ES; Lilic D; Ryan KR; Gennery AR; Cant AJ; Abinun M; Spickett GP; Arkwright PD; Denning D; Costigan C; Dominguez M; McConnell V; Willcox N; Meager A
J Clin Endocrinol Metab; 2008 Nov; 93(11):4389-97. PubMed ID: 18728167
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of anti-interferon -α2 and anti-interferon -ω antibody in myasthenia gravis].
Qi Y; Zhang LJ; Zhang QX; Wang J; Yang L
Zhonghua Yi Xue Za Zhi; 2019 Nov; 99(41):3227-3231. PubMed ID: 31694117
[No Abstract] [Full Text] [Related]
18. Do titin and cytokine antibodies in MG patients predict thymoma or thymoma recurrence?
Buckley C; Newsom-Davis J; Willcox N; Vincent A
Neurology; 2001 Nov; 57(9):1579-82. PubMed ID: 11706095
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin.
Williams CL; Hay JE; Huiatt TW; Lennon VA
Lab Invest; 1992 Mar; 66(3):331-6. PubMed ID: 1538587
[TBL] [Abstract][Full Text] [Related]
20. Anti-cytokine autoantibodies preceding onset of autoimmune polyendocrine syndrome type I features in early childhood.
Wolff AS; Sarkadi AK; Maródi L; Kärner J; Orlova E; Oftedal BE; Kisand K; Oláh E; Meloni A; Myhre AG; Husebye ES; Motaghedi R; Perheentupa J; Peterson P; Willcox N; Meager A
J Clin Immunol; 2013 Nov; 33(8):1341-8. PubMed ID: 24158785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
